Trial Profile
A Phase II, Multi-Centre, Controlled Study of the Safety and Efficacy of Wound Healing Gel I-020502 (KUR-212) in Patients Undergoing Autologous Meshed Skin Grafting.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2016
Price :
$35
*
At a glance
- Drugs KUR 212 (Primary)
- Indications Burns
- Focus Adverse reactions
- Sponsors Kuros Biosurgery
- 09 May 2014 New trial record